The success of Viagra initially fueled a period of growth for pharma, however recent shifts present a murky picture for investors. Off-patent versions are reducing revenue, and continued patent challenges add more https://jaysonrblt019689.imblogs.net/91016509/the-blue-pill-and-pharma-a-precarious-bet